IOL Chemicals & Pharmaceuticals informs about outcome of board meeting

17 May 2025 Evaluate
IOL Chemicals & Pharmaceuticals has informed that the Board of Directors in its meeting held on today 16th May 2025 has considered and approved: the Audited Financial Results (Standalone & Consolidated) for the Quarter and Year ended 31st March 2025. Ashwani & Associates, Chartered Accountants, the Statutory Auditors of the Company have issued Auditors' Reports with an Unmodified Opinion on the Financial Results of the Company for the Financial Year ended 31st March 2025. The Financial Results along with Auditors’ Report thereon, are enclosed as Annexure 1. Further, pursuant to Regulation 33(3)(d) of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Statutory Auditors, Ashwani & Associates, Chartered Accountants, have issued the Audit Reports on the Standalone and Consolidated Financial Results of the Company for the Financial Year ended 31st March 2025, with unmodified opinion; the re-appointment of Vikas Gupta as Joint Managing Director of the Company, subject to the approval of shareholders of the Company at their ensuing Annual General Meeting for a period of 5 years with effect from 29th May 2025. Vikas Gupta is not debarred from holding the office of director by virtue of any order of SEBI or any other such authority; the appointment of B.K. Gupta & Associates, Practicing Company Secretaries, as Secretarial Auditors of the Company subject to the approval of shareholders of the Company at their ensuing Annual General Meeting for a term of 5 consecutive years from FY 2025-26 to FY 2029-30; the reconstitution of Audit Committees, Nomination & Remuneration Committee, Stakeholder’s Relationship Committee, Corporate Social Responsibility Committee and Risk Management Committee of the Board. The details of the Committees are given in Annexure 2.

The above information is a part of company’s filings submitted to BSE.

IOL Chem & Pharma Share Price

84.53 -2.29 (-2.64%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×